Clinical Trial

Dexmedetomidine as an Adjuvant to Bupivacaine for Ultrasound-Guided External Oblique Intercostal Block

Study acronym: Dexmedetomidin
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2025 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Effect of Adding Dexmedetomidine as Adjuvant toBupivacaine in Ultrasound Guided ExternalOblique Intercostal Plane Block in UpperAbdominal Cancer Surgery.
Trial Details
NCT Number NCT07263165
Lead Sponsor Assiut University
Conditions Opioid Consumption, Postoperative
Enrollment 54 participants
Start Date 2025-12-15
Primary Completion 2026-02-15 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-04